A new peer-reviewed study published in the Journal of the American Heart Association, JAHA, found that Hello Heart’s digital heart health program was associated with reductions in blood pressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight.
News | Cardiovascular Clinical Studies
Study in JAHA Links Hello Heart Usage to Significant Reductions in Blood Pressure, Cholesterol, and Weight

May 23, 2024 — A newly-published peer-reviewed study in the Journal of the American Heart Association, JAHA, found that ...

Home May 23, 2024
Home
The REVEALPLAQUE trial was a large, global prospective study which enrolled 258 patients across 15 sites in the U.S. and Japan
News | FFR Technologies
HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study

May 23, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, announced ...

Home May 23, 2024
Home
Real-life data highlights need for patient-centered management of unhealthy cholesterol 
News | Cardiovascular Clinical Studies
Real-life Data Highlights Need for Patient-centered Management of Unhealthy Cholesterol

May 23, 2024 — Global Heart Hub, the international alliance of heart patient organizations, announced the first findings ...

Home May 23, 2024
Home
New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical Center, The University of Texas at Tyler and University of Alabama at Birmingham, shows that exercising, even at very high levels, is not related to the progression of coronary artery calcium (CAC)
News | Heart Failure
Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium

May 22, 2024 — New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical ...

Home May 22, 2024
Home
Voiant (USA) and Thirona (The Netherlands) are pleased to announce they have entered a global commercial partnership, combining Voiant's expertise in supporting clinical trials in pulmonary drug and treatment development with Thirona's expertise in advanced lung image analysis
News | Cardiovascular Business
Voiant and Thirona Announce Commercial Partnership for Full Scope Services in Imaging-based Clinical Trials for Pulmonary Diseases

May 22, 2024 — Voiant (USA) and Thirona (The Netherlands) announced they have entered a global commercial partnership ...

Home May 22, 2024
Home
Artificial intelligence (AI)-driven health technology company, Anumana, which developed the FDA-approved ECG-AI LEF algorithm, has announced its receipt of the International Organization for Standardization (ISO) 13485 certification for its Quality Management System.
News | Artificial Intelligence
Cardiac Care AI Company, Anumana, Announces Receipt of ISO 13485 Certification

May 21, 2024 — Anumana, a Cambridge, MA-based artificial intelligence (AI)-driven health technology company and ...

Home May 21, 2024
Home
Stereotaxis will present an innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablation therapy in underserved regions of Africa
News | EP Lab
Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home May 21, 2024
Home
Correlation between transcriptomic age and other epigenetic aging predictors
News | Cardiovascular Clinical Studies
Association of Inflammatory and Metabolic Biomarkers and Accelerated Aging in Cardiac Catheterization Patients

May 21, 2024 — A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging ...

Home May 21, 2024
Home
Ochsner Medical Center - Baton Rouge has earned The Joint Commission’s Gold Seal of Approval and the American Stroke Association’s Heart-Check mark for Acute Stroke Ready Certification
News | Stroke
Ochsner Medical Center-Baton Rouge earns Acute Stroke Ready Certification from Joint Commission

May 20, 2024 — Ochsner Medical Center - Baton Rouge has earned The Joint Commission’s Gold Seal of Approval and the ...

Home May 20, 2024
Home
Cardiologist Brendan Carry, MD, and a team of Geisinger Medical Center physicians have enrolled the first patient in the U.S. into a cardiac amyloidosis trial. Image courtesy: Geisinger Medical Center/Mark Dastrup
News | Cardiovascular Clinical Studies
Geisinger Enrolls First Patient in Amyloid Cardiomyopathy Trial

May 20, 2024 — Cardiologist Brendan Carry, MD, and a team of Danville, PA-based Geisinger Medical Center physicians have ...

Home May 20, 2024
Home
Early Cardiac Resynchronization Therapy (CRT) may slow the progression of heart failure in patients with mild to moderately reduced left ventricular ejection fraction (LVEF) and left bundle branch block (LBBB), according to a study conducted by a research team led by Yong-Mei Cha, MD, cardiac electrophysiologist at Mayo Clinic, Rochester, MN, presented during the Heart Rhythm Society meeting, HRS 2024.
News | HRS
Clinical Trial Presented at HRS 2024 Shows Benefits of Early Cardiac Resynchronization Therapy (CRT) in Slowing Progression of Heart Failure

May 19, 2024 — A physician-initiated prospective, randomized clinical trial sponsored by the National Heart, Lung, and ...

Home May 18, 2024
Home
Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM Subcutaneous Implantable Defibrillator and EMPOWER Leadless Pacemaker
News | Cardiovascular Clinical Studies
MODULAR ATP Study of the mCRM System Meets Primary Safety and Efficacy Endpoints

May 18, 2024 — Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ...

Home May 18, 2024
Home
During the Heart Rhythm Society (HRS) annual meeting, HRS 2024, findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), for patients with atrial fibrillation (AF) were presented. Learn more of the late-breaking science from the FARADISE, admIRE Study, and Advent Trial here.
News | HRS
Late-breaking Clinical Trial Results from FARADISE, admIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment

May 18, 2024 — The Heart Rhythm Society (HRS) has announced the findings of three new studies demonstrating the safety ...

Home May 18, 2024
Home
Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs
News | Cardiovascular Clinical Studies
Philips Presents Study Results at Heart Rhythm Annual Meeting Demonstrating Benefits of its AI-powered Cardiac Monitoring Solutions

May 17, 2024 — Royal Philips, a global leader in health technology, is presenting new retrospective study results ...

Home May 17, 2024
Home
Baseline characteristics from FINE-HEART analysis highlight complex interplay between cardiovascular, kidney, and metabolic health, with over 92% of patients presenting two or more conditions
News | Cardiovascular Clinical Studies
Study Design and Baseline Characteristics of Prespecified, Exploratory Pooled Analysis to Investigate Effect of Finerenone on Cardio-Kidney Outcomes in Patients with CKD and Type 2 Diabetes/Heart Failure

May 17, 2024 — The study design and baseline characteristics of FINE-HEART, a new prespecified, exploratory pooled ...

Home May 17, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now